| MLPR | URE | MLPR / URE | |
| Gain YTD | 32.222 | 18.466 | 174% |
| Net Assets | 57.3M | 57.8M | 99% |
| Total Expense Ratio | N/A | 0.95 | - |
| Turnover | N/A | 5.00 | - |
| Yield | 9.00 | 2.07 | 435% |
| Fund Existence | 6 years | 19 years | - |
| MLPR | URE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 89% | N/A |
| Stochastic ODDS (%) | 2 days ago 83% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 87% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 85% |
| Advances ODDS (%) | 2 days ago 90% | 8 days ago 86% |
| Declines ODDS (%) | 18 days ago 84% | 10 days ago 89% |
| BollingerBands ODDS (%) | 2 days ago 90% | N/A |
| Aroon ODDS (%) | 2 days ago 67% | 2 days ago 81% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MUIGX | 19.71 | N/A | N/A |
| Nationwide BNY Mellon Dyn US Core R6 | |||
| BUIEX | 63.41 | N/A | N/A |
| Buffalo Blue Chip Growth Instl Cl | |||
| FSIRX | 9.41 | N/A | N/A |
| Fidelity Advisor Strategic Real Ret I | |||
| MSHOX | 12.89 | N/A | N/A |
| Morgan Stanley Inst Permanence C | |||
| JFNAX | 87.90 | -0.63 | -0.71% |
| Janus Henderson Global Life Sciences A | |||
A.I.dvisor tells us that URE and EQIX have been poorly correlated (+18% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that URE and EQIX's prices will move in lockstep.
| Ticker / NAME | Correlation To URE | 1D Price Change % | ||
|---|---|---|---|---|
| URE | 100% | -3.29% | ||
| EQIX - URE | 18% Poorly correlated | N/A | ||
| VTR - URE | 14% Poorly correlated | -1.76% | ||
| WELL - URE | 12% Poorly correlated | -1.55% | ||
| NNN - URE | 10% Poorly correlated | -1.16% | ||
| Z - URE | 8% Poorly correlated | N/A | ||
More | ||||